Hims & Hers Health, Inc. (HIMS) announced that eligible customers can now access six months of prescription-only Wegovy at a new, affordable price. The company, via this offer, aims to make proven obesity care and treatments more accessible, affordable and connected for Americans.The latest product availability is expected to significantly boost HIMS’ business across the nation.Likely Trend of HIMS Stock Following the NewsFollowing the announcement, shares of the company lost nearly 8% till yesterday’s clos ...